Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells J Schrader, TT Gordon‐Walker, RL Aucott, M van Deemter, A Quaas, ... Hepatology 53 (4), 1192-1205, 2011 | 757 | 2011 |
The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus T Volz, L Allweiss, MB ḾBarek, M Warlich, AW Lohse, JM Pollok, ... Journal of hepatology 58 (5), 861-867, 2013 | 414 | 2013 |
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis C Weiler-Normann, C Schramm, A Quaas, C Wiegard, C Glaubke, ... Journal of hepatology 58 (3), 529-534, 2013 | 273 | 2013 |
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus U Reichelt, P Duesedau, MC Tsourlakis, A Quaas, BC Link, PG Schurr, ... Modern Pathology 20 (1), 120-129, 2007 | 258 | 2007 |
Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients T Volz, M Lutgehetmann, P Wachtler, A Jacob, A Quaas, JM Murray, ... Gastroenterology 133 (3), 843-852, 2007 | 252 | 2007 |
FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency M Peiseler, M Sebode, B Franke, F Wortmann, D Schwinge, A Quaas, ... Journal of hepatology 57 (1), 125-132, 2012 | 222 | 2012 |
Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis J Katt, D Schwinge, T Schoknecht, A Quaas, I Sobottka, E Burandt, ... Hepatology 58 (3), 1084-1093, 2013 | 193 | 2013 |
Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis J Hartl, U Denzer, H Ehlken, R Zenouzi, M Peiseler, M Sebode, ... Journal of hepatology 65 (4), 769-775, 2016 | 177 | 2016 |
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis H Mehanna, M Taberna, C Von Buchwald, S Tous, J Brooks, M Mena, ... The Lancet Oncology 24 (3), 239-251, 2023 | 156 | 2023 |
Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms M Sebode, M Peiseler, B Franke, D Schwinge, T Schoknecht, F Wortmann, ... Journal of hepatology 60 (5), 1010-1016, 2014 | 141 | 2014 |
Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma A Lechner, H Schlößer, SI Rothschild, M Thelen, S Reuter, P Zentis, ... Oncotarget 8 (27), 44418, 2017 | 139 | 2017 |
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer M Kluth, S Harasimowicz, L Burkhardt, K Grupp, A Krohn, K Prien, J Gjoni, ... International journal of cancer 135 (6), 1369-1380, 2014 | 138 | 2014 |
Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma A Lechner, HA Schlößer, M Thelen, K Wennhold, SI Rothschild, R Gilles, ... Oncoimmunology 8 (3), 1535293, 2019 | 137 | 2019 |
Quality control stress test for deep learning-based diagnostic model in digital pathology B Schömig-Markiefka, A Pryalukhin, W Hulla, A Bychkov, J Fukuoka, ... Modern Pathology 34 (12), 2098-2108, 2021 | 119 | 2021 |
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma K Shigeta, A Matsui, H Kikuchi, S Klein, E Mamessier, IX Chen, S Aoki, ... Journal for immunotherapy of cancer 8 (2), 2020 | 117 | 2020 |
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort … HS Muti, LR Heij, G Keller, M Kohlruss, R Langer, B Dislich, JH Cheong, ... The Lancet Digital Health 3 (10), e654-e664, 2021 | 106 | 2021 |
L1 is associated with micrometastatic spread and poor outcome in colorectal cancer JT Kaifi, U Reichelt, A Quaas, PG Schurr, R Wachowiak, EF Yekebas, ... Modern pathology 20 (11), 1183-1190, 2007 | 106 | 2007 |
Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma K Leuchte, E Staib, M Thelen, P Gödel, A Lechner, P Zentis, ... Cancer Immunology, Immunotherapy 70, 893-907, 2021 | 102 | 2021 |
Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas D Helbig, MA Ihle, K Pütz, I Tantcheva-Poor, C Mauch, R Büttner, A Quaas Oncotarget 7 (16), 21763, 2016 | 88 | 2016 |
Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication M Lutgehetmann, T Volz, A Quaas, M Zankel, C Fischer, M Dandri, ... Antiviral therapy 13 (1), 57-66, 2008 | 87 | 2008 |